This is the authors' abstract. We don't add key points for this paper.
The review considers the effectiveness of modern methods of nuclear medicine in the diagnosis of radiation disease to normal tissues in patients after radiation and radionuclide therapy. At the present stage, the assessment of radiation disease in the use of radiation and radionuclide therapy using nuclear medicine is one of the priority tasks in oncology. Hybrid methods of nuclear medicine have the ability to objectively identify and evaluate high-resolution radiation disease to normal tissues in order to predict and monitor the effects of radiation and radionuclide therapy on them.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Korol et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: